BioCentury | Jun 26, 2019
Distillery Therapeutics

Induction of NFE2L2 activity for Alzheimer's disease

...UCB S.A. market the NFE2L2 activator Tecfidera dimethyl fumarate and CinnaGen Pharmaceutical Group markets CinnoTec biosimilar dimethyl fumarate...
BioCentury | Nov 27, 2017
Distillery Therapeutics

Autoimmune disease; musculoskeletal; neurology; renal

...S.A. market the NFE2L2 activator Tecfidera dimethyl fumarate for MS. CinnaGen Pharmaceutical Group markets CinnoTec, biosimilar dimethyl fumarate...
Items per page:
1 - 2 of 2